search
Company Information
USD
221.61
- (-1.4%)
NYSE:CRL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Industry: Diagnostics & Research
End of Day: 17 May 2024 GMT-4
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Address

251 Ballardvale Street

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Mr. William D. Barbo
Executive VP/Other Executive Officer
Ms. Reshema Kemps-Polanco
Director
Dr. Deborah T. Kochevar
Director
Mr. James C. Foster
CEO/Chairman of the Board/Director/President
Dr. Martin W. Mackay, PhD
Director
Dr. Craig B. Thompson,M.D.
Director
Mr. C. Richard Reese
Director
Mr. George E. Massaro
Director
Mr. Richard F. Wallman
Director
Mr. Robert J. Bertolini
Director
Ms. Virginia M. Wilson
Director
Mr. Michael Gunnar Knell
Chief Accounting Officer/Senior VP
Ms. Victoria L. Creamer
Executive VP
Dr. Nancy C. Andrews, M.D.,PhD
Director
Ms. Birgit Girshick
COO
Mr. Joseph W. LaPlume
Executive VP, Divisional
Mr. George Llado, Sr
Director
Ms. Flavia H. Pease
CFO/Executive VP
Ms. Shannon M. Parisotto
Executive VP

Ownership

Institution Holdings

Vanguard Group Inc
5,980,306 (11.646%)
BlackRock Inc
5,161,360 (10.051%)
State Street Corporation
2,059,785 (4.011%)
Kayne Anderson Rudnick Investment Management LLC
1,753,238 (3.414%)
BlackRock Fund Advisors
1,716,221 (3.342%)
Vanguard Investments Australia Ltd
1,638,629 (3.191%)
ClearBridge Advisors, LLC
1,468,059 (2.859%)
T. Rowe Price Associates, Inc.
1,443,175 (2.810%)
Fidelity Management & Research Company LLC
1,296,324 (2.525%)
Allspring Global Investments Holdings, LLC
1,165,306 (2.269%)

Individual Holdings

Mr. James C. Foster
224,613 (0.437%)
Mr. C. Richard Reese
65,541 (0.128%)
Ms. Birgit Girshick
47,691 (0.093%)
Mr. Robert J. Bertolini
31,849 (0.062%)
Mr. Joseph W. LaPlume
24,620 (0.048%)
Mr. Richard F. Wallman
22,528 (0.044%)
Thier Samuel O Md
18,230 (0.037%)
Ms. Victoria L. Creamer
13,550 (0.026%)
Dr. Martin W. Mackay, PhD
11,600 (0.023%)
Ms. Flavia H. Pease
8,900 (0.017%)

Funds Holdings

Vanguard Total Stock Market Index Fund
1,611,680 (3.139%)
Vanguard US Total Market Shares ETF
1,611,680 (3.139%)
Vanguard Small Cap Index
1,309,216 (2.550%)
Vanguard Institutional 500 Index Trust
1,267,733 (2.469%)
Allspring Special US Mid Cap Value Eq
974,714 (1.898%)
Vanguard Small Cap Growth Index Fund
730,552 (1.423%)
Fidelity 500 Index Fund
609,038 (1.186%)
SPDR® S&P 500 ETF Trust
599,160 (1.167%)
iShares Core S&P 500 ETF
534,036 (1.040%)
Invesco S&P 500® Equal Weight ETF
455,641 (0.887%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices